{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:59:30Z","timestamp":1787893170528,"version":"build-2784847793"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Limited literature is available about the effects of extended (&gt;24 hours) antibiotic use after primary and aseptic revision total joint arthroplasty (TJA) on rates of periprosthetic joint infection (PJI). The purpose of this study was to systematically review the outcomes of extended prophylactic antibiotic use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic search on PubMed and EMBASE databases was done in August 2021 following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Articles that met inclusion criteria were screened by two separate authors. Basic patient demographics, route of delivery, type, dose, frequency of the antibiotic, rates of PJI, and length of stay were extracted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 11 articles published from 1979 to 2021 were included in the final analysis. Two studies evaluated aseptic revisions, seven evaluated primary TJA, and two studies evaluated both. Five studies were randomized controlled trials, one multicenter nonrandomized trial, and five retrospective cohort studies. All 11 studies used a cephalosporin or a penicillin antibiotic in both the control and cohort groups. Five studies used intravenous (IV) antibiotics, one study used oral (PO) antibiotics, and the other five studies used both IV and PO antibiotics. Length of stay was reported in three studies, all using IV antibiotics. All 11 studies evaluated rates of PJI, while four studies evaluated included rates of superficial surgical site infections. Four studies showed a statistically significant decrease in PJI when compared with a control group, while seven studies showed no statistically significant difference.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>There is conflicting evidence regarding the benefit of extended (&gt;24 hours) antibiotics, IV or PO, after TJA. As of now, current guidelines do not support the use of extended antibiotics; future prospective clinical trials are needed to help support these claims.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-21-00977","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T15:00:08Z","timestamp":1646406008000},"page":"e822-e832","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Extended Postoperative Prophylactic Antibiotics for Primary and Aseptic Revision Total Joint Arthroplasty: A Systematic Review"],"prefix":"10.5435","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7112-0139","authenticated-orcid":false,"given":"Ramakanth R.","family":"Yakkanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9515-9070","authenticated-orcid":false,"given":"Dennis","family":"Vanden Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer H.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailey L.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia C.","family":"Lavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor H.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3899\/jrheum.170990","article-title":"Rates of total joint replacement in the United States: Future projections to 2020-2040 using the national inpatient sample","volume":"46","author":"Singh","year":"2019","journal-title":"J Rheumatol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0039-3400755","article-title":"Extended oral antibiotics and infection prophylaxis after a primary or revision total knee arthroplasty","volume":"33","author":"Hong","year":"2020","journal-title":"J Knee Surg"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.arth.2012.02.022","article-title":"Economic burden of periprosthetic joint infection in the United States","volume":"27","author":"Kurtz","year":"2012","journal-title":"J Arthroplasty"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0140-6736(14)61798-0","article-title":"Periprosthetic joint infection","volume":"387","author":"Kapadia","year":"2016","journal-title":"Lancet"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.idc.2017.01.008","article-title":"Diagnosis of prosthetic joint infection: Cultures, biomarker and criteria","volume":"31","author":"Gomez-Urena","year":"2017","journal-title":"Infect Dis Clin North Am"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.arth.2018.02.078","article-title":"The 2018 definition of periprosthetic hip and knee infection: An evidence-based and validated criteria","volume":"33","author":"Parvizi","year":"2018","journal-title":"J Arthroplasty"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMra040181","article-title":"Prosthetic-joint infections","volume":"351","author":"Zimmerli","year":"2004","journal-title":"N Engl J Med"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11420-019-09698-8","article-title":"Extended antibiotic prophylaxis may be linked to lower peri-prosthetic joint infection rates in high-risk patients: An evidence-based review","volume":"15","author":"DeFrancesco","year":"2019","journal-title":"HSS J"},{"key":"R10-20250503","first-page":"161","article-title":"The effective period of preventive antibiotic action in experimental incisions and dermal lesions","volume":"50","author":"Burke","year":"1961","journal-title":"Surgery"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199201303260501","article-title":"The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection","volume":"326","author":"Classen","year":"1992","journal-title":"N Engl J Med"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1302\/0301-620X.95B11.33135","article-title":"Proceedings of the international consensus on periprosthetic joint infection","volume":"95","author":"Parvizi","year":"2013","journal-title":"Bone Joint J"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.arth.2018.09.012","article-title":"Hip and knee section, prevention, antimicrobials (systemic): Proceedings of international consensus on orthopedic infections","volume":"34","author":"Aboltins","year":"2019","journal-title":"J Arthroplasty"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.artd.2018.01.003","article-title":"Postoperative prophylactic antibiotics in total joint arthroplasty","volume":"4","author":"Yates","year":"2018","journal-title":"Arthroplast Today"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.2106\/JBJS.17.01485","article-title":"Extended oral antibiotic prophylaxis in high-risk patients substantially reduces primary total hip and knee arthroplasty 90-day infection rate","volume":"100","author":"Inabathula","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.arth.2021.01.051","article-title":"The AAHKS clinical research award: Extended oral antibiotics prevent periprosthetic joint infection in high-risk cases: 3855 patients with 1-year follow-up","volume":"36","author":"Kheir","year":"2021","journal-title":"J Arthroplasty"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/bmj.1.6165.707","article-title":"Antibiotic prophylaxis in total hip replacement","volume":"1","author":"Pollard","year":"1979","journal-title":"Br Med J"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2106\/00004623-199401000-00006","article-title":"Prophylaxis against infection in total joint arthroplasty. One day of cefuroxime compared with three days of cefazolin","volume":"76","author":"Mauerhan","year":"1994","journal-title":"J Bone Joint Surg Am"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(81)92678-7","article-title":"Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomised trial","volume":"1","author":"Hill","year":"1981","journal-title":"Lancet"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00003086-198306000-00037","article-title":"One day versus seven days of preventive antibiotic therapy in orthopedic surgery","volume":"176","author":"Nelson","year":"1983","journal-title":"Clin Orthop Relat Res"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00003086-198604000-00022","article-title":"Short-term preventive antibiotics","volume":"205","author":"Heydemann","year":"1986","journal-title":"Clin Orthop Relat Res"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2106\/JBJS.N.01141","article-title":"Prevalence of total hip and knee replacement in the United States","volume":"97","author":"Maradit Kremers","year":"2015","journal-title":"J Bone Joint Surg Am"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1089\/sur.2015.044","article-title":"A prolonged post-operative antibiotic regimen reduced the rate of prosthetic joint infection after aseptic revision knee arthroplasty","volume":"16","author":"Claret","year":"2015","journal-title":"Surg Infect (Larchmt)"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jac\/dku250","article-title":"The clinical presentation of prosthetic joint infection","volume":"69","author":"Barrett","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1016\/j.arth.2019.06.012","article-title":"Extended antibiotic prophylaxis confers no benefit following aseptic revision total hip arthroplasty: A matched case-controlled study","volume":"34","author":"Kuo","year":"2019","journal-title":"J Arthroplasty"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1086\/512192","article-title":"Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: Timely administration is the most important factor","volume":"44","author":"van Kasteren","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/acr.22233","article-title":"Time trends in the characteristics of patients undergoing primary total knee arthroplasty","volume":"66","author":"Singh","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00003086-200111000-00003","article-title":"Infection in total knee replacement: A retrospective review of 6489 total knee replacements","author":"Peersman","year":"2001","journal-title":"Clin Orthop Relat Res"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11999-014-3780-x","article-title":"The Otto Aufranc Award: Modifiable versus nonmodifiable risk factors for infection after hip arthroplasty","volume":"473","author":"Maoz","year":"2015","journal-title":"Clin Orthop Relat Res"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1471-2474-15-441","article-title":"Increasing obesity and comorbidity in patients undergoing primary total hip arthroplasty in the U.S.: A 13-year study of time trends","volume":"15","author":"Singh","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/j.arth.2021.03.018","article-title":"Do extended oral postoperative antibiotics prevent early periprosthetic joint infection in morbidly obese patients undergoing primary total joint arthroplasty?","volume":"36","author":"Carender","year":"2021","journal-title":"J Arthroplasty"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2106\/JBJS.18.00990","article-title":"Perioperative antibiotic prophylaxis in total joint arthroplasty: A systematic review and meta-analysis","volume":"101","author":"Siddiqi","year":"2019","journal-title":"J Bone J Surg"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/sur.2008.0020","article-title":"In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"10","author":"Baquero","year":"2009","journal-title":"Surg Infect (Larchmt)"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1161\/01.CIR.101.25.2916","article-title":"Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance","volume":"101","author":"Harbarth","year":"2000","journal-title":"Circulation"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/AAC.13.2.214","article-title":"Gentamicin use and Pseudomonas and Serratia resistance: Effect of a surgical prophylaxis regimen","volume":"13","author":"Roberts","year":"1978","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-21-00977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:43:20Z","timestamp":1787669000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-21-00977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-21-00977","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]},"assertion":[{"value":"2021-09-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}